Mandate

Vinge has advised Northmill Group AB in connection with the issuance of tier 2 capital bonds (T2)

Vinge has advised Northmill Group AB in connection with its successful issuance of SEK 100 million tier 2 capital bonds (T2) with a floating rate interest of 3-month STIBOR + 650 basis points.

The issuance represents Northmill’s first Tier 2 bond and strengthens its capital base whilst laying the foundation for continued profitable growth. The capital also enables the achievement of previously stated financial targets, whilst highlighting Northmill’s position as an innovative market player. Northmill Group is the parent company of Northmill Bank, a Swedish challenger bank providing financial services for both consumer and business customers.

DNB Carnegie acted as sole bookrunner in connection with the bond issuance.

Vinge’s team consisted of Albert Wållgren, Lionardo Ojeda, Caroline Krassén and Nilufer Nouri.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026